Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pyxis Oncology (PYXS) EBT Margin (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed EBT Margin for 2 consecutive years, with 154.04% as the latest value for Q4 2025.

  • Quarterly EBT Margin changed N/A to 154.04% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 568.26% through Dec 2025, down 6299.0% year-over-year, with the annual reading at 564.55% for FY2025, 7220.0% down from the prior year.
  • EBT Margin for Q4 2025 was 154.04% at Pyxis Oncology, up from 640.82% in the prior quarter.
  • The five-year high for EBT Margin was 33.09% in Q1 2024, with the low at 640.82% in Q2 2025.